119 related articles for article (PubMed ID: 11071364)
21. Ehrlich ascites carcinoma: synchronised ultradian rhythms in certain cell parameters.
Litinskay LL; Kostenko GA; Veksler AM; Eidus LK
Int J Chronobiol; 1978; 5(1):295-306. PubMed ID: 618828
[TBL] [Abstract][Full Text] [Related]
22. The triterpenoid fraction from Trichosanthes dioica root exhibits antiproliferative activity against Ehrlich ascites carcinoma in albino mice: involvement of possible antioxidant role.
Bhattacharya S; Haldar PK
J Exp Ther Oncol; 2012; 9(4):281-90. PubMed ID: 22545421
[TBL] [Abstract][Full Text] [Related]
23. Circadian influence on the immunization of mice with live Bacillus Calmette-Guérin (BCG) and subsequent challenge with Ehrlich ascites carcinoma.
Tsai TH; Burns RE; Scheving LE
Chronobiologia; 1979; 6(3):187-201. PubMed ID: 520096
[TBL] [Abstract][Full Text] [Related]
24. Modulation of tumor induced angiogenesis in Ehrlich ascites tumor.
Ghosh S; Roy S; Banerjee M; Maity P
J Exp Clin Cancer Res; 2004 Dec; 23(4):681-90. PubMed ID: 15743040
[TBL] [Abstract][Full Text] [Related]
25. Possible mechanism of interaction of GABAergic-adenosinergic systems in the regulation of theophylline-induced locomotor activity under its nontolerant and tolerant conditions.
Mandal M; Poddar MK
Neurochem Res; 1999 Jun; 24(6):757-65. PubMed ID: 10447459
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo evaluation of anisomycin against Ehrlich ascites carcinoma.
You P; Xing F; Huo J; Wang B; Di J; Zeng S; Liu J
Oncol Rep; 2013 Jun; 29(6):2227-36. PubMed ID: 23525555
[TBL] [Abstract][Full Text] [Related]
27. In vivo suppression of Ehrlich ascites carcinoma by human antibody-dependent splenocytes.
Dobaczewska H
Neoplasma; 1984; 31(2):165-8. PubMed ID: 6717686
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis-inducing Effect of a Palladium(II) Complex-[PdCl(terpy)](sac).2H2O] on Ehrlich Ascites Carcinoma (EAC) in Mice.
Ikitimur-Armutak EI; Ulukaya E; Gurel-Gurevin E; Yaylim I; Isbilen-Basok B; Sennazli G; Yuzbasioglu-Ozturk G; Sonmez K; Celik F; Kucukhuseyin O; Korkmaz G; Yilmaz VT; Zeybek SU
In Vivo; 2016; 30(4):457-64. PubMed ID: 27381609
[TBL] [Abstract][Full Text] [Related]
29. Trehalose enhances the antitumor potential of methotrexate against mice bearing Ehrlich ascites carcinoma.
El-Magd MA; Khamis A; Nasr Eldeen SK; Ibrahim WM; Salama AF
Biomed Pharmacother; 2017 Aug; 92():870-878. PubMed ID: 28599251
[TBL] [Abstract][Full Text] [Related]
30. Antineoplastic activity of N-(2-hydroxybenzylidene)2'-hydroxyphenylimine aqua nickel(II) complex [NI(H₂O)HHP] on ehrlich ascites carcinoma (EAC) in Swiss albino mice.
Hossain IA; Khanam JA; Jesmin M; Ali MM
Exp Toxicol Pathol; 2016 Jan; 68(1):15-25. PubMed ID: 26404919
[TBL] [Abstract][Full Text] [Related]
31. [Invasive tumor growth. Results of comparative histologic and electron microscopic as well as histo- and biochemical studies on the Ehrlich ascites carcinoma (EAC) implantation tumors in the mice].
Rath FW; Bonk U; Coutelle C; Coutelle R; Felicetti D; Traub F
Dtsch Gesundheitsw; 1971 May; 26(20):905-10. PubMed ID: 4941541
[No Abstract] [Full Text] [Related]
32. Modulation of GABA release from the thalamic reticular nucleus by cocaine and caffeine: role of serotonin receptors.
Goitia B; Rivero-Echeto MC; Weisstaub NV; Gingrich JA; Garcia-Rill E; Bisagno V; Urbano FJ
J Neurochem; 2016 Feb; 136(3):526-35. PubMed ID: 26484945
[TBL] [Abstract][Full Text] [Related]
33. Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity.
Sadzuka Y; Iwazaki A; Miyagishima A; Nozawa Y; Hirota S
Jpn J Cancer Res; 1995 Jun; 86(6):594-9. PubMed ID: 7622424
[TBL] [Abstract][Full Text] [Related]
34. Lactate dehydrogenase-elevating agent is responsible for interferon induction and enhancement of natural killer cell activity by inoculation of Ehrlich ascites carcinoma cells into mice.
Koi M; Saito M; Ebina T; Ishida N
Microbiol Immunol; 1981; 25(6):565-74. PubMed ID: 6168892
[TBL] [Abstract][Full Text] [Related]
35. Comparison of folylderivative biosynthesis in Ehrlich ascites carcinoma cells and in some organs of healthy and tumor-bearing mice.
Sikora E; Grzelakowska-Sztabert B
Neoplasma; 1984; 31(2):139-48. PubMed ID: 6717683
[TBL] [Abstract][Full Text] [Related]
36. [Various indices of the growth of Ehrlich ascites tumor].
Efimov ML; Degtiareva-Vasil'eva GS
Vopr Onkol; 1969; 15(1):54-8. PubMed ID: 5784518
[No Abstract] [Full Text] [Related]
37. [Capacity for differentiation and normalization of tumor cell populations transplanted into the anterior chamber. IV. Ehrlich ascites carcinoma].
Al-Rubey AK; Grigor'eva EG; Kulemina LIu; Shvemberger IN
Tsitologiia; 1984 Dec; 26(12):1376-83. PubMed ID: 6528361
[TBL] [Abstract][Full Text] [Related]
38. Induction of cytogenetic damage in human lymphocytes in vitro and of antineoplastic effects in Ehrlich ascites tumor cells in vivo treated by methotrexate, hyperthermia and/or caffeine.
Maskaleris T; Lialiaris T; Triantaphyllidis C
Mutat Res; 1998 Dec; 422(2):229-36. PubMed ID: 9838133
[TBL] [Abstract][Full Text] [Related]
39. Ottelione A inhibited proliferation of Ehrlich ascites carcinoma cells in mice.
El-Missiry MA; Othman AI; Amer MA; Mohamed E
Chem Biol Interact; 2012 Dec; 200(2-3):119-27. PubMed ID: 23131608
[TBL] [Abstract][Full Text] [Related]
40. GABAergic involvement in motor effects of an adenosine A(2A) receptor agonist in mice.
Khisti RT; Chopde CT; Abraham E
Neuropharmacology; 2000 Apr; 39(6):1004-15. PubMed ID: 10727710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
